What does BAL stand for?
BAL stands for B Aggressive Lymphoma
This definition appears somewhat frequently
See other definitions of BAL
Samples in periodicals archive:
One of the key differences between the aggressive forms of NHL and the indolent forms of NHL is that the aggressive types are quite often curable with intensive combination chemotherapy. The most common of the aggressive lymphomas is Diffuse Large B-cell Lymphoma, often called DLBC for short. In general, with modern treatment of patients with NHL, overall survival at 5 years is approximately 50% to 75% most of whom are cured.
The most frequently diagnosed subtype of non-Hodgkin's lymphoma is diffuse large B-cell lymphoma (DLBCL). This aggressive lymphoma subtype is curable.
The principles of treatment of DLBCL is described in the section on treatment of aggressive lymphomas. All patients receive chemotherapy. The most common regime is R-CHOP or CHOP for 6-8 cycles. Those in early stages also benefit from radiation to involved areas. Many patients, especially those in early stages of this lymphoma are cured of their cancer. Those who are not cured have options for further chemotherapy, antibody therapy and stem cell transplantation.
DLBCL can either develop as a transformation from a less aggressive form of lymphoma.
B-cell lymphomas include both Hodgkin's lymphomas and most non-Hodgkin lymphomas. They are typically divided into low and high grade, typically corresponding to indolent (slow-growing) lymphomas and aggressive lymphomas, respectively. As a generalisation, indolent lymphomas respond to treatment and are kept under control (in remission) with long-term survival of many years, but are not cured. Aggressive lymphomas usually require intensive treatments, with some having a good prospect for a permanent cure.